Search

Your search keyword '"Serfert, Yvonne"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Serfert, Yvonne" Remove constraint Author: "Serfert, Yvonne" Database Unpaywall Remove constraint Database: Unpaywall
31 results on '"Serfert, Yvonne"'

Search Results

3. Most vulnerable HCV patient groups treated with direct acting antivirals achieve high response rates and gain quality of life-data from the German hepatitis C-registry (DHC-R)

4. Zwischenbilanz

5. Clinical characteristics of patients with non-alcoholic fatty liver disease (NAFLD) in Germany – First data from the German NAFLD-Registry

6. Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany

8. Declining numbers of hepatitis-C-virus-associated liver transplantations in Germany

9. Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)

10. Only partial improvement in health‐related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real‐world setting—results from the German Hepatitis C‐Registry (DHC‐R)

11. Veränderungen der Hepatitis-C-Virus-Genotyp-1a/1b-Verteilung zwischen 2004 und 2018 in Deutschland – eine Analyse von 17093 Patienten aus verschiedenen Real-World-Registern

12. Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R)

13. Evolution of hepatitis C virus genotype 1a vs 1b distribution reflects profound changes in HCV epidemiology in Germany - analysis of 17,093 patients from five consecutive registries including the German hepatitis C-registry (DHC-R)

14. Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/ pibrentasvir in patients with advanced chronic kidney disease - data from the German hepatitis C-registry (DHC-R)

15. Treatment-failure to direct antiviral HCV regimens in real world: frequency, patient characteristics and rescue therapy – data from the German hepatitis C registry (DHC-R)

16. Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register)

17. THU-115-Effects of health-related quality of life of interferon-free antiviral therapy for chronic hepatitis C infection-Results from the GermanhHepatitis C-Registry (DHC-R)

18. THU-188-Retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C virus infection and prior DAA failure: An analysis from the German hepatitis C registry (DHC-R)

19. Deutsches Hepatitis C-Register (DHC-R) – eine Zwischenbilanz 4 Jahre nach Zulassung direkt antiviraler Substanzen (DAAs)

20. Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany

21. Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?

Catalog

Books, media, physical & digital resources